Apicomplexan Parasites: Molecular Approaches toward Targeted Drug Development [NOOK Book]

Be the first to write a review

Overview

This handbook is the first dealing with the discovery of drugs directed against apicomplexan parasites. Amongst others, this group of endoparasites includes the causative agents of Malaria, Toxoplasmosis, and Babesiosis, the latter occurring mainly in animals. Written by renowned scientific experts from academia and industry, the book focuses on currentdrug development approaches for all apicomplexan diseases making it appealing to a large audience, ranging from research labs in academia to the human and ...
See more details below
Apicomplexan Parasites: Molecular Approaches toward Targeted Drug Development

Available on NOOK devices and apps  
  • Nook Devices
  • NOOK HD/HD+ Tablet
  • NOOK
  • NOOK Color
  • NOOK Tablet
  • Tablet/Phone
  • NOOK for Windows 8 Tablet
  • NOOK for iOS
  • NOOK for Android
  • NOOK Kids for iPad
  • PC/Mac
  • NOOK for Windows 8
  • NOOK for PC
  • NOOK for Mac
  • NOOK Study
  • NOOK for Web

Want a NOOK? Explore Now

NOOK Book (eBook)
$96.87
BN.com price
(Save 43%)$169.95 List Price
Note: This NOOK Book can be purchased in bulk. Please email us for more information.

More About This Book

Overview

This handbook is the first dealing with the discovery of drugs directed against apicomplexan parasites. Amongst others, this group of endoparasites includes the causative agents of Malaria, Toxoplasmosis, and Babesiosis, the latter occurring mainly in animals. Written by renowned scientific experts from academia and industry, the book focuses on currentdrug development approaches for all apicomplexan diseases making it appealing to a large audience, ranging from research labs in academia to the human and veterinarian pharmaceutical industry. This work is the second volume of the new book series 'Drug Discovery in Infectious Diseases', edited by Prof. Dr Paul M. Selzer.
Read More Show Less

Product Details

  • ISBN-13: 9783527633906
  • Publisher: Wiley, John & Sons, Incorporated
  • Publication date: 1/19/2011
  • Series: Drug Discovery in Infectious Diseases , #1
  • Sold by: Barnes & Noble
  • Format: eBook
  • Edition number: 4
  • Pages: 544
  • File size: 6 MB

Meet the Author

Volume editor:
Prof. Dr. Katja Becker obtained her Academic Degree in Medicine at Heidelberg University. She carried out her doctoral-thesis as well as her Habilitation at the Biochemistry Centre, Heidelberg, before she obtained a Junior Group Leader Position at the Research Center for Infectious Diseases, Wurzburg University. Since 2000 she holds the Chair of Nutritional Biochemistry at the Justus-Liebig University Giessen. Scientifically she focuses on the characterization of redox active proteins as drug targets. She has produced more than 170 scientific publications and received numerous scientific awards including the Carus Medal of the German Academy of Sciences Leopoldina and the Leuckart Medal of the German Society for Parasitology. Since June 2009 she is a member of the Leopoldina.

Series Editor:
Prof. Dr. Paul M. Selzer studied Biology, Parasitology, and Biochemistry at the University of Tubingen, Germany, where he also received his PhD in Biochemistry. He spent three years in the parasitology and tropical disease laboratory of Prof. James H. McKerrow at the University of California, San Francisco (UCSF). During his professional career he worked as researcher and scientific manager for several pharmaceutical companies, being currently employed by Intervet Innovation GmbH, Germany, part of a leading Animal Health company. Dr. Selzer is also a visiting Professor and teacher in Biochemistry, Bioinformatics, and Chemoinformatics at the University of Tubingen, and holds an Honorary Professorship in the Department of Infection and Immunity at the University of Glasgow, UK.
Read More Show Less

Table of Contents

SCREENING, BIOINFORMATICS, CHEMOINFORMATICS, AND DRUG DESIGN
Drug Discovery Approaches towards Anti-Parasitic Agents
(Andreas Rohwer, Richard J. Marhofer, Conor R. Caffrey and Paul M. Selzer)
New Bioinformatic Strategies against Apicomplexan Parasites
(Thomas Dandekar and Ke Xiao)
Sorting Potential Therapeutic Targets in Apicomplexa
(Jan A. Hiss and Gisbert Schneider)

Alternatives to Drug Development in Apicomplexa
(Prof. Dr. Theo P.M. Schetters)

METABOLIC PATHWAYS AND PROCESSES ADDRESSED BY CURRENT DRUG DISCOVERY APPROACHES

The Energy Metabolism as an Antimalarial Drug Target
(Esther Jortzik and Katja Becker)
Polyamines in Apicomplexan Parasites
(Ingrid B. Muller, Robin Das Gupta, Kai Luersen, Carsten Wrenger and Rolf D. Walter)
The Reducing Milieu of Parasitized Cells as a Target of Antimalarial Agents. Methylene Blue as an Ethical Drug
(Peter Meissner, Heike Adler, Karin Fritz-Wolf and R. Heiner Schirmer)
Lipids as Drug Targets for Malaria Therapy
(Henri J. Vial, Diana Penarete, Sharon Wein, Sergio Caldarelli, Laurent Fraisse and Suzanne Peyrottes)
Targeting Apicoplast Pathways in Plasmodium
(Snober S. Mir, Subir Biswas and Saman Habib)
Lipoic Acid Acquisition and Glutathione Biosynthesis in Apicomplexan Parasites
(Janet Storm, Eva-Maria Patzewitz and Sylke Muller)
Antimalarial Drugs and Molecules Inhibiting Hemozoin formation
(Uday Bandyopadhyay and Sumanta Dey)
Exploiting the Vitamin Metabolism of Apicomplexa as Drug Targets
(Carsten Wrenger and Ingrid B. Muller)

Vitamin Biosynthetic Pathways, the PLP Synthase Complex, and the Potential for Drugging Protein-Protein Interaction
(Ivo Tews and Irmgard Sinning)
Targeting Prokaryotic Enzymes in the Eukaryotic Pathogen Cryptosporidium
(Suresh Kumar Gorla, Corey Johnson, Jihan Khan, Xin Sun, Lisa Sharling,
Boris Striepen and Lizbeth Hedstrom)

DRUG TARGETS IN APICOMPLEXAN PARASITES
Novel Apicomplexan Phosphatases and Immunophilins
as Domain-Specific Drug Targets
(Sailen Barik)
Dehydrogenases and enzymes of the mitochondrial electron transport chain as antiapicomplexan drug targets
(Kathleen Zocher, Stefan Rahlfs and Katja Becker)
Calcium-dependent protein kinases as drug targets in apicomplexan parasites
(Dominik Kugelstadt, Bianca Derrer, and Barbara Kappes)

Protein Acylation:
New Potential Targets for Intervention against Apicomplexa
(Joana M. Santos, Christian Hedberg and Dominique Soldati-Favre)
Drugs and Drug Targets in Neospora Caninum and Related Apicomplexans
(Joachim Muller, Norbert Muller and Andrew Hemphill)

COMPOUNDS
Subversive Substrates of Glutathione Reductases from P. Falciparum-infected Red Blood Cells as Antimalarial Agents
(Elisabeth Davioud-Charvet and Don Antoine Lanfranchi)
Ferroquine: a Concealed Weapon (Christophe Biota, Bruno Pradinesb and Daniel Divec)

Current Aspects of Endoperoxides in Antiparasitic Chemotherapy
(Denis Matovu Kasozi, Stefan Rahlfs and Katja Becker)

Plasmodium Hsp90 as an Antimalarial Target
(G. Sridhar Prasad and Sailen Barik)
Drug Discovery against Babesia and Toxoplasma
(Mohamad Alaa Terkawi and Ikuo Igarashi)
Search for Drugs and Drug Targets against Babesia bovis, Babesia bigemina, Babesia caballi, and Babesia (Theileria) equi
(Sabine Bork-Mimm)
Orlistat: A Repositioning Opportunity as a Growth Inhibitor of Apicomplexan Parasites?
(Christian Miculka, Hon Tran, Thorsten Meyer, Anja R. Heckeroth, Stefan Baumeister, Frank Seeber and Paul M. Selzer)
Recent drug discovery against Cryptosporidium
(Jean-Francois Rossignol, Gilles Gargala, J. Edward Semple and Andrew V. Stachulski)

Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Review Guidelines
Add Recommendations
Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously
    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)